Connect your AI

ANI Pharmaceuticals ANIP Income Tax

Income Tax at other companies

Amneal Pharmaceuticals, Inc.AMRX

$2.18M-83.1%

ViatrisVTRS

-$423.7M-670%

AnaptysBio, Inc.ANAB

$40K-9.1%

ALN

Alnylam PharmaceuticalsALNY

$15.66M-1.4%

Aurinia PharmaceuticalsAUPH

$9.57M+852%

AmgenAMGN

$265M+9.1%

Other financials

Income statement

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

Market cap$1.88B+18.3%

Profitability

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ANI Pharmaceuticals's income tax?: ANI Pharmaceuticals (ANIP) reported income tax of $10.73M in Q1 2026.
How has ANI Pharmaceuticals's income tax changed year-over-year?: ANI Pharmaceuticals's income tax increased by 149.2% year-over-year, from $4.31M to $10.73M.
What is the long-term trend for ANI Pharmaceuticals's income tax?: Over 3 years (2021 to 2025), ANI Pharmaceuticals's income tax has grown at a 9.1% compound annual growth rate (CAGR), from -$13.46M to $17.45M.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.